Clinical Trials
3 trialsNCT03190174 2025-02-17
Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers
Sarcoma Oncology Research Center, LLC
Phase 1/2 Completed
NCT02494570 2023-04-07
AMPECT
Aadi Bioscience, Inc.
Phase 2 Completed
NCT02334930 2016-08-22
PEC-Hem
University Hospital, Bordeaux
Completed